Rx Medicare

Medicare News

Flower

Xanodyne Receives Approval From The U.S. Food And Drug Administration For ZIPSOR(TM) (diclofenac Potassium) Liquid Filled Capsules

Xanodyne Pharmaceuticals, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Zipsor (diclofenac potassium) Liquid Filled Capsules, a new treatment option indicated for relief of mild to moderate acute pain in adults (18 years of age or older). “Zipsor is a drug with several unique features,” said Gary A. Shangold, Chief Medical Officer of Xanodyne.

Read More…

  • Share/Bookmark

Related Posts

Tags: , , , , , , , , , , ,

Comments are closed.